Kymera Therapeutics, Inc. Logo

Kymera Therapeutics, Inc.

Fintech firm providing data analytics and market intelligence for investment professionals.

KYMR | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
500 NORTH BEACON STREET, 4TH FLOOR, 2472 WATERTOWN
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kymera Therapeutics, Inc. is a revolutionary financial technology firm redefining investment paradigms through targeted data analytics. Leveraging its powerful and highly productive data discovery engine, the company delivers a pipeline of first-in-class analytics and market intelligence solutions for financial institutions and investment professionals. Kymera's platform provides a market-agnostic modality for discovering alpha and managing risk, fundamentally changing how clients access and utilize data. The firm is committed to delivering transformative insights with precision, focus, and a sense of urgency to a global client base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 13:15
Quarterly Report
10-Q - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 2.2 MB
2025-11-04 13:10
Regulatory News Service
8-K - Kymera Therapeutics, Inc. (0001815442) (Filer)
English 225.9 KB

Automate Your Workflow. Get a real-time feed of all Kymera Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kymera Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kymera Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America IBIO
Ibotta, Inc. Logo
A performance marketing platform offering cash-back rewards to consumers from CPG brands.
United States of America IBTA
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America ICLR
IDEAYA Biosciences, Inc. Logo
Clinical-stage firm developing precision cancer therapies via synthetic lethality.
United States of America IDYA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
IMMERSION CORP Logo
Licenses patented haptic feedback technology for mobile, gaming, and automotive interfaces.
United States of America IMMR
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America IMUX

Talk to a Data Expert

Have a question? We'll get back to you promptly.